Your browser doesn't support javascript.
loading
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
Nyati, Shyam; Stricker, Hans; Barton, Kenneth N; Li, Pin; Elshaikh, Mohamed; Ali, Haythem; Brown, Stephen L; Hwang, Clara; Peabody, James; Freytag, Svend O; Movsas, Benjamin; Siddiqui, Farzan.
Afiliação
  • Nyati S; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Stricker H; Department of Radiology, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, United States of America.
  • Barton KN; Vattikuti Urology Institute, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Li P; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Elshaikh M; Department of Public Health Sciences, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Ali H; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Brown SL; Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Hwang C; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Peabody J; College of Human Medicine, Michigan State University, East Lansing, Michigan, United States of America.
  • Freytag SO; Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Movsas B; Vattikuti Urology Institute, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
  • Siddiqui F; Department of Radiation Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan, United States of America.
PLoS One ; 18(9): e0291315, 2023.
Article em En | MEDLINE | ID: mdl-37713401
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Terapia Viral Oncolítica Limite: Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Adenocarcinoma / Terapia Viral Oncolítica Limite: Humans / Male Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos